These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 24218223)

  • 1. Bicontinuous cubic liquid crystalline nanoparticles for oral delivery of Doxorubicin: implications on bioavailability, therapeutic efficacy, and cardiotoxicity.
    Swarnakar NK; Thanki K; Jain S
    Pharm Res; 2014 May; 31(5):1219-38. PubMed ID: 24218223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced antitumor efficacy and counterfeited cardiotoxicity of combinatorial oral therapy using Doxorubicin- and Coenzyme Q10-liquid crystalline nanoparticles in comparison with intravenous Adriamycin.
    Swarnakar NK; Thanki K; Jain S
    Nanomedicine; 2014 Aug; 10(6):1231-41. PubMed ID: 24637217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral delivery of doxorubicin using novel polyelectrolyte-stabilized liposomes (layersomes).
    Jain S; Patil SR; Swarnakar NK; Agrawal AK
    Mol Pharm; 2012 Sep; 9(9):2626-35. PubMed ID: 22871060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phytantriol Based "Stealth" Lyotropic Liquid Crystalline Nanoparticles for Improved Antitumor Efficacy and Reduced Toxicity of Docetaxel.
    Jain S; Bhankur N; Swarnakar NK; Thanki K
    Pharm Res; 2015 Oct; 32(10):3282-92. PubMed ID: 25968624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved Oral Bioavailability, Therapeutic Efficacy, and Reduced Toxicity of Tamoxifen-Loaded Liquid Crystalline Nanoparticles.
    Jain S; Heeralal B; Swami R; Swarnakar NK; Kushwah V
    AAPS PharmSciTech; 2018 Jan; 19(1):460-469. PubMed ID: 28785860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lyotropic liquid crystalline nanoparticles of CoQ10: implication of lipase digestibility on oral bioavailability, in vivo antioxidant activity, and in vitro-in vivo relationships.
    Swarnakar NK; Thanki K; Jain S
    Mol Pharm; 2014 May; 11(5):1435-49. PubMed ID: 24742138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel self-assembly albumin nanocarrier for reducing doxorubicin-mediated cardiotoxicity.
    Yuan A; Wu J; Song C; Tang X; Qiao Q; Zhao L; Gong G; Hu Y
    J Pharm Sci; 2013 May; 102(5):1626-35. PubMed ID: 23423631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipomer of doxorubicin hydrochloride for enhanced oral bioavailability.
    Benival DM; Devarajan PV
    Int J Pharm; 2012 Feb; 423(2):554-61. PubMed ID: 22155412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymersomes via Self-Assembly of Amphiphilic β-Cyclodextrin-Centered Triarm Star Polymers for Enhanced Oral Bioavailability of Water-Soluble Chemotherapeutics.
    Hu M; Shen Y; Zhang L; Qiu L
    Biomacromolecules; 2016 Mar; 17(3):1026-39. PubMed ID: 26840277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid-based liquid crystalline nanoparticles as oral drug delivery vehicles for poorly water-soluble drugs: cellular interaction and in vivo absorption.
    Zeng N; Gao X; Hu Q; Song Q; Xia H; Liu Z; Gu G; Jiang M; Pang Z; Chen H; Chen J; Fang L
    Int J Nanomedicine; 2012; 7():3703-18. PubMed ID: 22888230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanometronomic treatment of 4T1 breast cancer with nanocaged doxorubicin prevents drug resistance and circumvents cardiotoxicity.
    Mazzucchelli S; Bellini M; Fiandra L; Truffi M; Rizzuto MA; Sorrentino L; Longhi E; Nebuloni M; Prosperi D; Corsi F
    Oncotarget; 2017 Jan; 8(5):8383-8396. PubMed ID: 28039473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stealth, biocompatible monoolein-based lyotropic liquid crystalline nanoparticles for enhanced aloe-emodin delivery to breast cancer cells: in vitro and in vivo studies.
    Freag MS; Elnaggar YS; Abdelmonsif DA; Abdallah OY
    Int J Nanomedicine; 2016; 11():4799-4818. PubMed ID: 27703348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin- and quercetin-loaded liquid crystalline nanoparticles: implications on oral bioavailability, antidiabetic and antioxidant efficacy.
    Singh S; Kushwah V; Agrawal AK; Jain S
    Nanomedicine (Lond); 2018 Mar; 13(5):521-537. PubMed ID: 29383973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of DOX bioavailability in biological samples of mice by sensitive and precise HPLC assay.
    Zhang C; Wu Y; Dong Y; Xu H; Zhao L
    Pharm Biol; 2016; 54(1):55-61. PubMed ID: 25880143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The chemotherapeutic potential of doxorubicin-loaded PEG-b-PLGA nanopolymersomes in mouse breast cancer model.
    Alibolandi M; Sadeghi F; Abnous K; Atyabi F; Ramezani M; Hadizadeh F
    Eur J Pharm Biopharm; 2015 Aug; 94():521-31. PubMed ID: 26170161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of biodegradable nanoparticles for oral delivery of doxorubicin: in vivo pharmacokinetics and toxicity studies in rats.
    Kalaria DR; Sharma G; Beniwal V; Ravi Kumar MN
    Pharm Res; 2009 Mar; 26(3):492-501. PubMed ID: 18998202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid nanoemulsions loaded with doxorubicin-oleic acid ionic complex: characterization, in vitro and in vivo studies.
    Zhang X; Sun X; Li J; Zhang X; Gong T; Zhang Z
    Pharmazie; 2011 Jul; 66(7):496-505. PubMed ID: 21812324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. pH Responsiveness of Hexosomes and Cubosomes for Combined Delivery of
    Li Y; Angelova A; Hu F; Garamus VM; Peng C; Li N; Liu J; Liu D; Zou A
    Langmuir; 2019 Nov; 35(45):14532-14542. PubMed ID: 31635451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Doxorubicin/heparin composite nanoparticles for caspase-activated prodrug chemotherapy.
    Khaliq NU; Sandra FC; Park DY; Lee JY; Oh KS; Kim D; Byun Y; Kim IS; Kwon IC; Kim SY; Yuk SH
    Biomaterials; 2016 Sep; 101():131-42. PubMed ID: 27286189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen-anchored pH-sensitive liposomes as nanomodule designed for site-specific delivery of doxorubicin in breast cancer therapy.
    Paliwal SR; Paliwal R; Pal HC; Saxena AK; Sharma PR; Gupta PN; Agrawal GP; Vyas SP
    Mol Pharm; 2012 Jan; 9(1):176-86. PubMed ID: 22091702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.